Who Buys Sertraline from India — 553 Importers Behind a $560.5M Market
India's sertraline import market is served by 553 active buyers who collectively imported $560.5M across 5,183 shipments. CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) leads with a 52.7% market share, followed by YUSEN LOGISTICS BENELUX BELGIUM and APL SWIFT SERVICES (MALTA) LTD.,. The top 5 buyers together control 77.2% of total import value, reflecting a concentrated buyer landscape.
Top Sertraline Importers — Ranked by Import Value
CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) is the leading sertraline importer from India, holding a 52.7% share of the $560.5M market across 5,183 shipments from 553 buyers. The top 5 buyers — CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES), YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), APL SWIFT SERVICES (MALTA) LTD., (MALTA), ORION CORPORATION, (FINLAND), KYOWA PHARMACEUTICAL IND.CO.,LTD., (JAPAN) — collectively control 77.2% of total import value.
Top Sertraline Buyers & Importers
Ranked by import value · 553 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | CIPLA USA INC UPS SUPPLY CHAIN SOLUUNITED STATES SERTRALINE TABLETS, USP 25 MG NDC 69097-833-12 ANDA 077397 | $295.6M | 5 | 52.7% |
| 2 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM SERTRALINE SUN TAB 100MG PACK : BOX 2X14SERTRALINE TABLETS 100MG PACK :BOX 2X14SSERTRALINE TABLETS 50MG (SERTRALINE SUN | $55.1M | 5 | 9.8% |
| 3 | APL SWIFT SERVICES (MALTA) LTD.,MALTA SERTRALINE HYDROCHLORIDE TABLETS 50MG(SESERTRALINE HYDROCHLORIDE TABLETS 100MG(SSERTRALINE 100MG TABLETS(SERTRALINE AURO | $34.3M | 5 | 6.1% |
| 4 | ORION CORPORATION,FINLAND SERTRALINE 100MG TABLETS(SERTRALIN ORIONSERTRALINE 50MG TABLETS(SERTRALIN ORIONSERTRALINE 50MG TABLETS (SERTRALIN ORION | $24.3M | 5 | 4.3% |
| 5 | KYOWA PHARMACEUTICAL IND.CO.,LTD.,JAPAN PHARMA : SERTRALINE TABLETS 50MG KYOWA JAPAN - 1'SPHARMA : SERTRALINE TABLETS 25MG KYOWA JAPAN - 1'SPHARMA : SERTRALINE TABLETS 50MG KYOWA J | $23.4M | 5 | 4.2% |
| 6 | CIPLA USA INC UPS SUPPLY CHAIN SOLUNITED STATES SERTRALINE TABLETS, USP 25 MG NDC 69097-833-12 ANDA 077397 | $8.8M | 5 | 1.6% |
| 7 | ZAO TORRENTPHARMARUSSIA OTHER - SERENATA 50 TABLET ( SERTRALINEOTHERSSERENATA 100 TABLETSERTRALINE 1SERENATA 100 TABLET NOS=3X10 TAB | $6.1M | 5 | 1.1% |
| 8 | AUROBINDO PHARMA USA INCUNITED STATES SERTRALINE TABLETS, USP 25 MG NDC 69097-833-12 ANDA 077397 | $5.1M | 5 | 0.9% |
| 9 | GRANULES PHARMACEUTICALS, INCUNITED STATES SERTRALINE TABLETS, USP 25 MG NDC 69097-833-12 ANDA 077397 | $3.6M | 5 | 0.6% |
| 10 | XXROBXXDO XXARMXXUSAXX INXXUNITED STATES SERTRALINE TABLETS, USP 25 MG NDC 69097-833-12 ANDA 077397 | $3.5M | 5 | 0.6% |
| 11 | GRANULES PHARMACEUTICALS INCUNITED STATES SERTRALINE TABLETS, USP 25 MG NDC 69097-833-12 ANDA 077397 | $3.4M | 5 | 0.6% |
| 12 | AURO PHARMA INC,CANADA SERTRALINE TABLETS, USP 25 MG NDC 69097-833-12 ANDA 077397SERTRALINE 100MG CAPSULES(AURO-SERTRALINSERTRALINE CAPSULES 25MG(AURO-SERTRALINE | $3.3M | 5 | 0.6% |
| 13 | YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAANBELGIUM SERTRALINE SUN TAB 100MG PACK : BOX 2X14SERTRALINE TABLETS 100MG PACK :BOX 2X14SSERTRALINE TABLETS 50MG (SERTRALINE SUN | $2.8M | 5 | 0.5% |
| 14 | GRANULES PHARMACEUTICALS, INC.UNITED STATES SERTRALINE TABLETS, USP 25 MG NDC 69097-833-12 ANDA 077397 | $2.6M | 5 | 0.5% |
| 15 | MEDPRO PHARMACEUTICA (PTY) LTD..SOUTH AFRICA | $2.5M | 5 | 0.4% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Sertraline — and from which countries?
Flow of Sertraline exports from India: each country's share and the named importers behind the numbers
Sertraline — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $338.0M through 695 shipments. This represents a market share of 60.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $295.6M (87.5% of country's total business)
• CIPLA USA INC UPS SUPPLY CHAIN SOL - $8.8M (2.6% of country's total business)
• AUROBINDO PHARMA USA INC - $5.1M (1.5% of country's total business)
• GRANULES PHARMACEUTICALS, INC - $3.6M (1.1% of country's total business)
• XXROBXXDO XXARMXXUSAXX INXX - $3.5M (1.0% of country's total business)
• Rest of United States's importers - $21.3M (6.3% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $486.3K, indicating premium pricing strategy compared to the market average of $108.1K.
United States is a key market for Sertraline imports, representing 60.3% of total trade value.
2Belgium
Belgium emerges as the second largest importing country, achieving a total trade value of $58.2M through 332 shipments. This represents a market share of 10.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $55.1M (94.7% of country's total business)
• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN - $2.8M (4.8% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $175.3K, indicating premium pricing strategy compared to the market average of $108.1K.
Belgium is a key market for Sertraline imports, representing 10.4% of total trade value.
3Malta
Malta emerges as the third largest importing country, achieving a total trade value of $35.6M through 237 shipments. This represents a market share of 6.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Malta has a diverse importer base, with their top importers including:
• APL SWIFT SERVICES (MALTA) LTD., - $34.3M (96.2% of country's total business)
Key Insight: Malta demonstrates strong market positioning with an average shipment value of $150.3K, indicating premium pricing strategy compared to the market average of $108.1K.
Malta is a key market for Sertraline imports, representing 6.4% of total trade value.
4Finland
Finland emerges as the fourth largest importing country, achieving a total trade value of $25.9M through 57 shipments. This represents a market share of 4.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Finland has a diverse importer base, with their top importers including:
• ORION CORPORATION, - $24.3M (94.1% of country's total business)
Key Insight: Finland demonstrates strong market positioning with an average shipment value of $453.8K, indicating premium pricing strategy compared to the market average of $108.1K.
Finland is a key market for Sertraline imports, representing 4.6% of total trade value.
5Japan
Japan emerges as the fifth largest importing country, achieving a total trade value of $25.0M through 45 shipments. This represents a market share of 4.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Japan has a diverse importer base, with their top importers including:
• KYOWA PHARMACEUTICAL IND.CO.,LTD., - $23.4M (93.4% of country's total business)
Key Insight: Japan demonstrates strong market positioning with an average shipment value of $556.1K, indicating premium pricing strategy compared to the market average of $108.1K.
Japan is a key market for Sertraline imports, representing 4.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Sertraline buyer market intelligence
1Buyer Segment Analysis
The importation of Sertraline from India involves various buyer segments, each with distinct purchasing behaviors and order patterns:
1. Distributors: Entities like Yusen Logistics Benelux Belgium (Belgium, $55.11M) and APL Swift Services (Malta) Ltd. (Malta, $34.28M) function as intermediaries, procuring large quantities of Sertraline to supply regional markets. Their purchasing patterns are characterized by bulk orders to achieve economies of scale, ensuring consistent supply to pharmacies and healthcare providers.
2. Contract Manufacturers: Companies such as Orion Corporation (Finland, $24.33M) and Kyowa Pharmaceutical Ind. Co., Ltd. (Japan, $23.38M) import Sertraline for incorporation into their own pharmaceutical products. Their procurement is driven by production schedules and demand forecasts, leading to regular, sizable orders to maintain manufacturing continuity.
3. Re-exporters: Entities like APL Swift Services (Malta) Ltd. (Malta, $34.28M) may also act as re-exporters, importing Sertraline to distribute to other countries. This segment's buying behavior involves strategic procurement to serve multiple markets, often leveraging favorable trade agreements or logistical advantages.
4. Government Procurement: While not explicitly listed among the top buyers, government agencies and international organizations such as UNICEF and the Global Fund engage in tender-based purchasing of Sertraline for public health programs. Their procurement processes are typically characterized by large-volume orders through competitive bidding, aiming to secure cost-effective supplies for national healthcare initiatives.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Sertraline buyer market intelligence
1Country-Specific Import Regulations
The top five importing countries of Sertraline from India—United States, Belgium, Malta, Finland, and Japan—each have distinct regulatory frameworks governing the importation of pharmaceuticals:
1. United States:
2. Belgium:
3. Malta:
4. Finland:
5. Japan:
Navigating these regulatory landscapes requires thorough preparation and compliance with each country's specific requirements to ensure successful market entry.
Demand Drivers & Market Opportunity
TransData Nexus Sertraline buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Sertraline in importing countries is influenced by several key factors:
1. Prevalence of Mental Health Disorders: The global rise in depression and anxiety disorders has significantly increased the need for effective antidepressants like Sertraline. According to the World Health Organization (WHO), over 970 million individuals worldwide were living with mental disorders as of 2023, underscoring the growing demand for such medications.
2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are enhancing their healthcare systems to provide broader access to mental health services. For instance, the European Union's focus on mental health has led to increased procurement of antidepressants through national health services, facilitating greater access to treatments like Sertraline.
3. WHO Essential Medicines List Procurement: Sertraline's inclusion in the WHO Essential Medicines List encourages its adoption in national formularies, promoting its availability in public health systems. This inclusion supports consistent demand across various regions.
4. Tender-Based Purchasing: Government and international health organizations often procure pharmaceuticals through competitive tenders to ensure cost-effectiveness and supply security. This procurement method contributes to substantial and predictable demand for Sertraline, particularly in countries with centralized healthcare purchasing systems.
With 553 buyers across 88 countries, the market for Sertraline presents significant opportunities for suppliers. Understanding the specific demand drivers in each region enables targeted strategies to effectively meet the needs of diverse healthcare systems.
Common Questions — Sertraline Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest sertraline buyer importing from India?
Based on import volume and value, CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) leads with $295.6M in imports and a 52.7% market share — the highest of any single sertraline importer. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) and APL SWIFT SERVICES (MALTA) LTD., (MALTA) are the next largest buyers.
QHow many companies buy sertraline from India?
There are 553 active sertraline buyers importing from India, with a combined market of $560.5M across 5,183 shipments to 88 countries. The top 5 buyers hold 77.2% of total import value, while the remaining 548 buyers handle the other 22.8%.
QWhich countries import the most sertraline from India?
The top importing countries for sertraline from India are United States (60.3%), Belgium (10.4%), Malta (6.4%), Finland (4.6%), Japan (4.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of sertraline, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for sertraline from India?
The average import transaction value for sertraline from India is $108.1K, with an average unit price of $2.15 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Sertraline buyer market intelligence
1Buyer Segment Analysis
The importation of Sertraline from India involves various buyer segments, each with distinct purchasing behaviors and order patterns:
1. Distributors: Entities like Yusen Logistics Benelux Belgium (Belgium, $55.11M) and APL Swift Services (Malta) Ltd. (Malta, $34.28M) function as intermediaries, procuring large quantities of Sertraline to supply regional markets. Their purchasing patterns are characterized by bulk orders to achieve economies of scale, ensuring consistent supply to pharmacies and healthcare providers.
2. Contract Manufacturers: Companies such as Orion Corporation (Finland, $24.33M) and Kyowa Pharmaceutical Ind. Co., Ltd. (Japan, $23.38M) import Sertraline for incorporation into their own pharmaceutical products. Their procurement is driven by production schedules and demand forecasts, leading to regular, sizable orders to maintain manufacturing continuity.
3. Re-exporters: Entities like APL Swift Services (Malta) Ltd. (Malta, $34.28M) may also act as re-exporters, importing Sertraline to distribute to other countries. This segment's buying behavior involves strategic procurement to serve multiple markets, often leveraging favorable trade agreements or logistical advantages.
4. Government Procurement: While not explicitly listed among the top buyers, government agencies and international organizations such as UNICEF and the Global Fund engage in tender-based purchasing of Sertraline for public health programs. Their procurement processes are typically characterized by large-volume orders through competitive bidding, aiming to secure cost-effective supplies for national healthcare initiatives.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Sertraline buyer market intelligence
1Country-Specific Import Regulations
The top five importing countries of Sertraline from India—United States, Belgium, Malta, Finland, and Japan—each have distinct regulatory frameworks governing the importation of pharmaceuticals:
1. United States:
2. Belgium:
3. Malta:
4. Finland:
5. Japan:
Navigating these regulatory landscapes requires thorough preparation and compliance with each country's specific requirements to ensure successful market entry.
Demand Drivers & Market Opportunity
TransData Nexus Sertraline buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Sertraline in importing countries is influenced by several key factors:
1. Prevalence of Mental Health Disorders: The global rise in depression and anxiety disorders has significantly increased the need for effective antidepressants like Sertraline. According to the World Health Organization (WHO), over 970 million individuals worldwide were living with mental disorders as of 2023, underscoring the growing demand for such medications.
2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are enhancing their healthcare systems to provide broader access to mental health services. For instance, the European Union's focus on mental health has led to increased procurement of antidepressants through national health services, facilitating greater access to treatments like Sertraline.
3. WHO Essential Medicines List Procurement: Sertraline's inclusion in the WHO Essential Medicines List encourages its adoption in national formularies, promoting its availability in public health systems. This inclusion supports consistent demand across various regions.
4. Tender-Based Purchasing: Government and international health organizations often procure pharmaceuticals through competitive tenders to ensure cost-effectiveness and supply security. This procurement method contributes to substantial and predictable demand for Sertraline, particularly in countries with centralized healthcare purchasing systems.
With 553 buyers across 88 countries, the market for Sertraline presents significant opportunities for suppliers. Understanding the specific demand drivers in each region enables targeted strategies to effectively meet the needs of diverse healthcare systems.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 553 global importers of Sertraline identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 5,183 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 88 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,183 Verified Shipments
553 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists